Healthcare Equipment and Supplies
Company Overview of Bausch & Lomb Incorporated
Bausch & Lomb Incorporated develops, manufactures, and markets eye care products. It focuses on protecting, enhancing, and restoring people’s eyesight. The company offers contact and hydrophobic acrylic intraocular lenses; contact lens care, dry eye, allergy/redness relief, Rx pharmaceutical, and surgical products; and eye vitamins, vision accessories, and safety and industrial cleaning products. It also offers contract manufacturing services for sterile and non-sterile solutions, suspensions, ointments, gels, creams, nasals, and injectables. The company was formerly known as Bausch & Lomb Optical Company and changed its name to Bausch & Lomb Incorporated in March 1960. The company was found...
1400 North Goodman Street
Rochester, NY 14609
Founded in 1853
Key Executives for Bausch & Lomb Incorporated
President of Asia-Pacific
Corporate Vice President and President of Latin America Operations
Chief Medical Officer and Executive Vice President
Head of Sales for US Vision Care Division
Compensation as of Fiscal Year 2015.
Bausch & Lomb Incorporated Key Developments
Bausch + Lomb Announces 23-Gauge Fragmentation Needle Availability for Stellaris PC Vision Enhancement System
Aug 12 15
Bausch + Lomb announced the availability of a 23-gauge fragmentation needle for the Stellaris PC Vision Enhancement System. This new ultrasonic needle design is used during vitreoretinal procedures to effectively remove the lens material from the posterior chamber of the eye with balanced irrigation and aspiration through 23-gauge incisions providing enhanced intraoperative control and efficiency. Prior to its introduction, surgeons were required to use larger fragmentation needles in order to remove lens fragments during surgery, thus necessitating the need for increased incision size, suturing of the wounds and lengthened recovery time. Surgeons are now able to utilize the 23-gauge fragmentation needle to help balance the inflow and outflow in the eye and achieve a suture-less wound closure. When combined with the Stellaris PC with 23-gauge valve Entry Site Alignment system, this advancement will provide surgeons: Use of the existing cannula wound architecture to insert the 23-gauge fragmentation needle into the eye; Fluidic and intraocular pressure stability during lens nucleus removal, due to the consistency in gauge sizes for in-flow and outflow of fluid. Easy replacement of the original valved cannula in the same wound for completion of the procedure.
Bausch & Lomb Incorporated Receives FDA Clearance for its VICTUS Femtosecond Laser Platform
Aug 3 15
Bausch + Lomb announced that its VICTUS Femtosecond Laser Platform has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an enhanced patient interface kit. The interface features a smaller diameter suction clip, which has been modified to allow for easier opening and closing of the clip, based on customer feedback, to help facilitate more efficient placement of the clip in patients with narrow fissures and smaller eye openings. Additional features of the enhanced patient interface kit, which is intended to enhance the performance of the suction ring as well as laser operation function, include: Colored Suction Skirt: The colored skirt of the suction clip will help assist surgeons in achieving optimal centration to avoid the introduction of tilt as well as to optimize the inner working diameter of the suction ring. Eliminating such tilt will also help surgeons ensure that corneal incisions and arcuate incisions are placed accurately on the cornea. Multi-port Suction Design: Multiple suction ports along the inside of the ring were incorporated to assist surgeons in obtaining optimal control of the eye throughout the VICTUS Femtosecond laser procedure. The multi-port suction is designed to provide enhanced stability on the eye during laser planning and treatment while distributing the vacuum level throughout multiple ports to improve patient comfort during the procedure. Ergonomical Design: An enhanced contoured handle allows surgeons comfortable grip and improved control of the suction clip, including an easy lock/unlock feature.
Bausch + Lomb Announces Appointment of Brian Rosenblatt as Director, Professional Strategy
Jul 30 15
Bausch + Lomb has appointed Dr. Brian Rosenblatt, O.D., as director, Professional Strategy. Dr. Rosenblatt will join Dr. Jill Saxon and Todd Love, directors of Professional Strategy, in coordinating the company's Eye Care Professional (ECP) outreach efforts across Vision Care. In his new role, Dr. Rosenblatt is responsible for enhancing Bausch + Lomb's professional outreach program through its team of U.S. contact lens experts, maximizing communication and support through professional educational events, and continuing to forge relationships with key optometric industry members. Immediately prior to joining Bausch + Lomb, Dr. Rosenblatt was the president and co-owner of Rosenblatt Family Eye Care Associates, in Raritan, N.J. He will be based at the company's headquarters in Bridgewater, NJ.
Similar Private Companies By Industry
Recent Private Companies Transactions